Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Calidi Biotherapeutics (CLDI) has issued an announcement.
Calidi Biotherapeutics, Inc. has boosted the compensation package for executive Wendy Pizarro. As of May 13, 2024, her annual salary rose by $25,000 to $425,000, and her potential bonus increased to 40% of her base salary. Additionally, she stands to receive a $120,000 bonus if the company secures a $10 million funding round by the end of the year, with the CEO determining the final bonus based on her contribution.
For an in-depth examination of CLDI stock, go to TipRanks’ Stock Analysis page.